Gastroretentive Drug Delivery Systems Outsourcing Market Size, Share & Trends Analysis Report By Dosage Form (Tablets, Liquid, Microspheres, Capsule, Others), By Region, And By Segment Forecasts, 2023-2031
Gastroretentive Drug Delivery Systems Outsourcing Market Size is valued at USD 1.26 Bn in 2022 and is predicted to reach USD 2.32 Bn by the year 2031 at a 7.22% CAGR during the forecast period for 2023-2031.
Gastroretentive drug delivery systems are designed for extended retention within the stomach, allowing for direct interaction with ulcer sites and thereby increasing drug concentrations specifically at the affected areas. These systems enable sustained drug release and localized dosage delivery in the stomach and small intestine. The rising incidence of disorders related to the stomach and small intestine is anticipated to drive market demand.
Furthermore, the global increase in disease burdens, coupled with the demonstrated effectiveness of gastroretentive drug delivery systems in addressing conditions like peptic ulcers and gastric ulcers, is a significant driver for the market's expansion in the foreseeable future. These systems extend the retention time in the stomach, leading to enhanced drug concentration at the target site of application. Consequently, this improves drug bioavailability and reduces the required dosage, fueling the growth of the global gastroretentive drug delivery systems market.
Additionally, the growing prevalence of H. Pylori infection, responsible for gastritis, gastric cancer, and gastroduodenal ulcer disease, is also likely to contribute to market growth. Challenges related to ensuring that outsourcing partners possess adequate production capacity and scalability to meet escalating demand can be particularly limiting, especially during periods of rapid market growth.
Competitive Landscape
Some Major Key Players In The Gastroretentive Drug Delivery Systems Outsourcing Market:
- Catalent
- Lonza
- Evonik
- Colorcon
- Quotient Sciences
- Aptar Pharma
- Aenova Group
- Evotec
- Vectura Group Ltd.
- Ashland
- Calera Corporation
- Others
Market Segmentation:
The gastroretentive drug delivery systems outsourcing market is segmented on the basis of the dosage form. According to dosage form, the market is segmented as tablets, liquid, microspheres, capsules and others.
The Tablets Segment Witnessed Growth At A Rapid Rate.
The tablets segment is projected to grow rapidly in the global gastroretentive drug delivery systems outsourcing market. The growing emphasis of manufacturers on developing gastroretentive tablets is anticipated to propel the segment's expansion. Gastroretentive tablets are designed to offer controlled and prolonged release of medication, ensuring a consistent and sustained level of drugs in the bloodstream over an extended duration. This controlled release mechanism reduces the need for frequent dosing, enhancing patient convenience. Additionally, gastroretentive tablets can potentially enhance the bioavailability of certain medications, especially those with limited solubility or permeability.
In The Region, The North American Gastroretentive Drug Delivery Systems Outsourcing Market Holds A Significant Revenue Share.
The North American gastroretentive drug delivery systems outsourcing market is expected to record the maximum market share in terms of revenue in the near future. The expansion of this particular regional market can be attributed to the significant patient population it serves. Furthermore, the market is set to grow with the boost provided by increasing government backing for the pharmaceutical sector. In addition, Asia Pacific is estimeted to grow at a rapid rate in the global gastroretentive drug delivery systems outsourcing market. Several Asian nations have established regulations and incentives aimed at fostering pharmaceutical research and development, particularly in the realm of drug delivery technology. These initiatives hold the promise of attracting both domestic and international companies in search of outsourcing collaborations.
Recent Developments:
- In August 2022, Catalent revealed its intention to purchase Metrics Contract Services for USD 475 million. This strategic move aims to enhance Catalent's promising capabilities and increase its oral development and manufacturing capacity.
Gastroretentive Drug Delivery Systems Outsourcing Market Report Scope
| Report Attribute | Specifications |
| Market Size Value In 2022 | USD 1.26 Bn |
| Revenue Forecast In 2031 | USD 2.32 Bn |
| Growth Rate CAGR | CAGR of 7.22% from 2023 to 2031 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2023 to 2031 |
| Historic Year | 2019 to 2022 |
| Forecast Year | 2023-2031 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | By Dosage |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; South East Asia; South Korea; South East Asia |
| Competitive Landscape | Catalent, Lonza, Evonik, Colorcon, Quotient Sciences, Aptar Pharma, Aenova Group, Evotec, Vectura Group Ltd., Ashland, Calera Corporation |
| Customization Scope | Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape. |
| Pricing And Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
Segmentation of Gastroretentive Drug Delivery Systems Outsourcing Market-
Gastroretentive Drug Delivery Systems Outsourcing Market By Dosage Form
- Tablets
- Liquid
- Microspheres
- Capsule
- Others
Gastroretentive Drug Delivery Systems Outsourcing Market By Region-
North America-
- The US
- Canada
- Mexico
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of Middle East and Africa
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Gastroretentive Drug Delivery Systems Outsourcing Market Size is valued at USD 1.26 Bn in 2022 and is predicted to reach USD 2.32 Bn by the year 2031
Gastroretentive Drug Delivery Systems Outsourcing Market is expected to grow at a 7.22% CAGR during the forecast period for 2023-2031.
Lonza, Evonik, Colorcon, Quotient Sciences, Aptar Pharma, Aenova Group, Evotec, Vectura Group Ltd., Ashland, Calera Corporation
Dosage form is the key segment of the Gastroretentive Drug Delivery Systems Outsourcing Market
North American region is leading the Gastroretentive Drug Delivery Systems Outsourcing Market.